Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-25 · accession 0001069530-22-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-28 | 2022-03-25 | FLNA | ROBERTSON SANFORD | Dir | M - OptEx | $20.30 | +4,670 | 924.8K | +0.5% | +$94.8K |
| D | 2022-03-28 | 2022-03-25 | FLNA | ROBERTSON SANFORD | Dir | M - OptEx | $20.30 | -4,670 | 0 | -100% | -$94.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-25 | M | A | 4,670 | $20.30 | 924,765 | D | — | — | |
| 2 | Derivative | Common Stock | 2022-03-25 | M | D | 4,670 | $20.30 | 0 | D | $20.30 · 2016-05-17 to 2022-05-17 | 4,670 Common Stock |